Prevention of chloroform and thiobarbiturate cardiac sensitization to catecholamines in dogs.
D000075:Acepromazine / Q000494:pharmacology; D000758:Anesthesia / Q000009:adverse effects / Q000662:veterinary; D000769:Anesthesia, Inhalation; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D002725:Chloroform / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D004283:Dog Diseases / Q000139:chemically induced / Q000517:prevention & control*; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine / Q000008:administration & dosage; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate; D007275:Injections, Intravenous; D009638:Norepinephrine / Q000008:administration & dosage; D011433:Propranolol / Q000494:pharmacology; D013840:Thiamylal / Q000494:pharmacology*; D013874:Thiopental / Q000494:pharmacology*; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000517:prevention & control / Q000662:veterinary*
D002395:Catecholamines; D013840:Thiamylal; D000075:Acepromazine; D002725:Chloroform; D011433:Propranolol; D013874:Thiopental; D002746:Chlorpromazine; D009638:Norepinephrine; D004837:Epinephrine